+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 2c0t | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | Src family kinase Hck with bound inhibitor A-641359 | ||||||
要素 | TYROSINE-PROTEIN KINASE HCK | ||||||
キーワード | TRANSFERASE / ATP-BINDING / KINASE / LIPOPROTEIN / MYRISTATE / NUCLEOTIDE-BINDING / PALMITATE / SH2 DOMAIN / SH3 DOMAIN | ||||||
| 機能・相同性 | 機能・相同性情報leukocyte degranulation / leukocyte migration involved in immune response / respiratory burst after phagocytosis / regulation of podosome assembly / innate immune response-activating signaling pathway / : / FLT3 signaling through SRC family kinases / regulation of phagocytosis / Nef and signal transduction / Fc-gamma receptor signaling pathway involved in phagocytosis ...leukocyte degranulation / leukocyte migration involved in immune response / respiratory burst after phagocytosis / regulation of podosome assembly / innate immune response-activating signaling pathway / : / FLT3 signaling through SRC family kinases / regulation of phagocytosis / Nef and signal transduction / Fc-gamma receptor signaling pathway involved in phagocytosis / mesoderm development / positive regulation of actin filament polymerization / FCGR activation / type II interferon-mediated signaling pathway / transport vesicle / Signaling by CSF3 (G-CSF) / peptidyl-tyrosine phosphorylation / cell projection / phosphotyrosine residue binding / FCGR3A-mediated IL10 synthesis / lipopolysaccharide-mediated signaling pathway / cell surface receptor protein tyrosine kinase signaling pathway / integrin-mediated signaling pathway / regulation of actin cytoskeleton organization / FCGR3A-mediated phagocytosis / non-specific protein-tyrosine kinase / Regulation of signaling by CBL / non-membrane spanning protein tyrosine kinase activity / negative regulation of inflammatory response to antigenic stimulus / Inactivation of CSF3 (G-CSF) signaling / caveola / cytoplasmic side of plasma membrane / cytokine-mediated signaling pathway / Signaling by CSF1 (M-CSF) in myeloid cells / protein autophosphorylation / regulation of cell shape / protein tyrosine kinase activity / regulation of inflammatory response / cytoskeleton / protein phosphorylation / cell differentiation / lysosome / cell adhesion / intracellular signal transduction / defense response to Gram-positive bacterium / inflammatory response / signaling receptor binding / focal adhesion / positive regulation of cell population proliferation / lipid binding / negative regulation of apoptotic process / Golgi apparatus / ATP binding / nucleus / plasma membrane / cytosol 類似検索 - 分子機能 | ||||||
| 生物種 | HOMO SAPIENS (ヒト) | ||||||
| 手法 | X線回折 / シンクロトロン / 分子置換 / 解像度: 2.15 Å | ||||||
データ登録者 | Borhani, D.W. / Burchat, A. / Calderwood, D.J. / Hirst, G.C. / Li, B. / Loew, A. | ||||||
引用 | ジャーナル: Bioorg.Med.Chem.Lett. / 年: 2006タイトル: Discovery of A-770041, a Src-Family Selective Orally Active Lck Inhibitor that Prevents Organ Allograft Rejection. 著者: Burchat, A. / Borhani, D.W. / Calderwood, D.J. / Hirst, G.C. / Li, B. / Stachlewitz, R.F. #1: ジャーナル: Bioorg.Med.Chem.Lett. / 年: 2004 タイトル: A-420983: A Potent, Orally Active Inhibitor of Lck with Efficacy in a Model of Transplant Rejection 著者: Borhani, D.W. / Calderwood, D.J. / Friedman, M.M. / Hirst, G.C. / Li, B. / Leung, A.K.W. / Mcrae, B. / Ratnofsky, S. / Ritter, K. / Waegell, W. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 2c0t.cif.gz | 193 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb2c0t.ent.gz | 152.6 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 2c0t.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/c0/2c0t ftp://data.pdbj.org/pub/pdb/validation_reports/c0/2c0t | HTTPS FTP |
|---|
-関連構造データ
-
リンク
-
集合体
| 登録構造単位 | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ![]()
| ||||||||
| 2 | ![]()
| ||||||||
| 単位格子 |
| ||||||||
| 非結晶学的対称性 (NCS) | NCS oper: (Code: given Matrix: (0.943572, 0.02456, -0.330255), ベクター: |
-
要素
| #1: タンパク質 | 分子量: 52000.227 Da / 分子数: 2 / 断片: SH3-SH2-SH1, RESIDUES 80-525 / 変異: YES / 由来タイプ: 組換発現 詳細: SRC NUMBERING USED. ADD 20 TO THE RESIDUE NUMBERS IN THIS ENTRY TO OBTAIN ACTUAL HUMAN HCK RESIDUE NUMBERS. RESIDUE Y501 (HCK Y521) IS PHOSPHORYLATED 由来: (組換発現) HOMO SAPIENS (ヒト) / Cell: LYMPHOCYTE / プラスミド: PBC HCK002 / 細胞株 (発現宿主): SF9発現宿主: ![]() 参照: UniProt: P08631, EC: 2.7.1.112 #2: 化合物 | #3: 化合物 | ChemComp-CA / #4: 水 | ChemComp-HOH / | 構成要素の詳細 | ENGINEERED RESIDUE IN CHAIN A, GLN 502 TO GLU ENGINEERED RESIDUE IN CHAIN A, GLN 503 TO GLU ...ENGINEERED | Has protein modification | Y | 配列の詳細 | THE PROTEIN CRYSTALLIZED INCLUDED EIGHT NON-NATIVE N-TERMINAL RESIDUES: GLY-ALA-MET-GLY-SER-GLY-ILE- ...THE PROTEIN CRYSTALLIZ | |
|---|
-実験情報
-実験
| 実験 | 手法: X線回折 / 使用した結晶の数: 1 |
|---|
-
試料調製
| 結晶 | マシュー密度: 3.1 Å3/Da / 溶媒含有率: 59.9 % 解説: INTENSITIES WERE CONVERTED TO STRUCTURE FACTORS USING CCP4 PROGRAM TRUNCATE. |
|---|---|
| 結晶化 | 温度: 277 K / 手法: 蒸気拡散法, シッティングドロップ法 / pH: 8 詳細: CRYSTALLIZATION CONDITIONS: HCK (10 MG/ML IN 150 MM NACL, 20 MM TRIS.HCL PH 8.0) WAS MIXED WITH A-641359 [100 MM STOCK SOLUTION OF THE MALEIC ACID SALT IN DMSO) TO GIVE A FINAL A-641359 ...詳細: CRYSTALLIZATION CONDITIONS: HCK (10 MG/ML IN 150 MM NACL, 20 MM TRIS.HCL PH 8.0) WAS MIXED WITH A-641359 [100 MM STOCK SOLUTION OF THE MALEIC ACID SALT IN DMSO) TO GIVE A FINAL A-641359 CONCENTRATION OF 1 MM. HCK/A-641359 WAS THEN MIXED WITH RESERVOIR SOLUTION (12% PEG 6000, 3% 1, 5-DIAMINOPENTANE, 20% GLYCEROL, 200 MM CA(OAC)2, 100 MM TRIS.HCL PH 8.0) AND EQUILBRATED AGAINST THE RESERVOIR SOLUTION BY VAPOR DIFFUSION (SITTING DROPS) AT 277 K. |
-データ収集
| 回折 | 平均測定温度: 100 K |
|---|---|
| 放射光源 | 由来: シンクロトロン / サイト: APS / ビームライン: 17-ID / 波長: 1 |
| 検出器 | タイプ: MARRESEARCH / 検出器: CCD / 日付: 2002年3月22日 |
| 放射 | モノクロメーター: SI(111) DOUBLE MONOCHROMATOR / プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
| 放射波長 | 波長: 1 Å / 相対比: 1 |
| 反射 | 解像度: 2.14→50 Å / Num. obs: 52558 / % possible obs: 75.6 % / Observed criterion σ(I): 0 / 冗長度: 3 % / Biso Wilson estimate: 38.1 Å2 / Rmerge(I) obs: 0.08 / Net I/σ(I): 13.6 |
| 反射 シェル | 解像度: 2.14→2.22 Å / 冗長度: 1.8 % / Rmerge(I) obs: 0.25 / Mean I/σ(I) obs: 3.3 / % possible all: 24.7 |
-
解析
| ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 精密化 | 構造決定の手法: 分子置換開始モデル: PDB ENTRY 1AD5 解像度: 2.15→20 Å / Cor.coef. Fo:Fc: 0.956 / Cor.coef. Fo:Fc free: 0.924 / SU B: 11.085 / SU ML: 0.148 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / ESU R: 0.307 / ESU R Free: 0.246 / 立体化学のターゲット値: MAXIMUM LIKELIHOOD 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. THE ACTIVATION LOOP (RESIDUES A386-A398 AND B386-B398) IS DISORDERED IN BOTH HCK MOLECULES (CHAINS A AND B). HCK CHAIN A IS SLIGHTLY BETTER ...詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. THE ACTIVATION LOOP (RESIDUES A386-A398 AND B386-B398) IS DISORDERED IN BOTH HCK MOLECULES (CHAINS A AND B). HCK CHAIN A IS SLIGHTLY BETTER ORDERED THAN CHAIN B. SIMILARLY, THE LIGAND A1506 IS BETTER ORDERED THAN B1506. SEVEN N-TERMINAL RESIDUES (FROM THE EXPRESSION VECTOR, GLY-ALA -MET-GLY-SER-GLY-ILE) ARE DISORDERED IN BOTH CHAINS. RESIDUE ARG-59 IS NON-NATIVE (EXPRESSION VECTOR).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 溶媒の処理 | イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: BABINET MODEL WITH MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 63.67 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 精密化ステップ | サイクル: LAST / 解像度: 2.15→20 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 拘束条件 |
|
ムービー
コントローラー
万見について




HOMO SAPIENS (ヒト)
X線回折
引用

























PDBj

















